Bionpharma Inc. — Form D/A
Bionpharma Inc. of PRINCETON, NJ, a company, filed a Form D amendment with the SEC on 2015-05-27. The offering totals $30.7M, of which $30.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-05-27
- Form: D/A
- Accession: 0001624663-15-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.7M
- Amount sold: $30.7M
- Investors: 10
- Date of first sale: 2014-11-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228203
Issuer
- Name: Bionpharma Inc.
- CIK: 0001624663
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 600 ALEXANDER ROAD, PRINCETON, NJ, 08540
- Phone: (609) 380-3310
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James Gale | Director | Gaithersburg, MD |
| Richard W Van Duyne | Director | Princeton, NJ |
| Venkatachalam Krishnan | Director | Princeton, NJ |
| Venkatachalam Krishnan | Executive Officer | Princeton, NJ |
| Carol S Ben-Maimon | Director | Princeton, NJ |
| Lavesh W Samtani | Executive Officer | Princeton, NJ |
| Gaurav W Mehrotra | Executive Officer | Princeton, NJ |
| David W Goodman | Director | — |
Other filings by this issuer (3)
More